Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction

Jérémie Ménager; Jean-Baptiste Gorin; Catherine Maurel; Lucile Drujont; Sébastien Gouard; Cédric Louvet; Michel Chérel; Alain Faivre-Chauvet; Alfred Morgenstern; Frank Bruchertseifer; François Davodeau; Joëlle Gaschet; Yannick Guilloux

doi:10.1371/journal.pone.0130249

Loading metrics

Open Access

Peer-reviewed

Research Article

Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction

Jérémie Ménager,

Affiliations CRCNA—UMR 892 INSERM, Nantes, France, 6299 CNRS, Nantes, France, Université de Nantes, Nantes, France
⨯
Jean-Baptiste Gorin,

Affiliations CRCNA—UMR 892 INSERM, Nantes, France, 6299 CNRS, Nantes, France, Université de Nantes, Nantes, France
⨯
Catherine Maurel,

Affiliations CRCNA—UMR 892 INSERM, Nantes, France, 6299 CNRS, Nantes, France, Université de Nantes, Nantes, France
⨯
Lucile Drujont,

Affiliation INSERM UMR 1064 –ITUN, Nantes, France
⨯
Sébastien Gouard,

Affiliations CRCNA—UMR 892 INSERM, Nantes, France, 6299 CNRS, Nantes, France, Université de Nantes, Nantes, France
⨯
Cédric Louvet,

Affiliation INSERM UMR 1064 –ITUN, Nantes, France
⨯
Michel Chérel,

Affiliations CRCNA—UMR 892 INSERM, Nantes, France, 6299 CNRS, Nantes, France, Université de Nantes, Nantes, France, Institut de Cancérologie de l’Ouest, Saint-Herblain, France
⨯
Alain Faivre-Chauvet,

Affiliations CRCNA—UMR 892 INSERM, Nantes, France, 6299 CNRS, Nantes, France, Université de Nantes, Nantes, France, CHU Nantes, Nuclear Medicine Department, Nantes, France
⨯
Alfred Morgenstern,

Affiliation European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany
⨯
Frank Bruchertseifer,

Affiliation European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany
⨯
François Davodeau,

Affiliations CRCNA—UMR 892 INSERM, Nantes, France, 6299 CNRS, Nantes, France, Université de Nantes, Nantes, France
⨯
Joëlle Gaschet ,

Contributed equally to this work with: Joëlle Gaschet, Yannick Guilloux

Affiliations CRCNA—UMR 892 INSERM, Nantes, France, 6299 CNRS, Nantes, France, Université de Nantes, Nantes, France
⨯
Yannick Guilloux

Contributed equally to this work with: Joëlle Gaschet, Yannick Guilloux

* E-mail: yannick.guilloux@univ-nantes.fr

Affiliations CRCNA—UMR 892 INSERM, Nantes, France, 6299 CNRS, Nantes, France, Université de Nantes, Nantes, France
⨯

Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction

Jérémie Ménager,
Jean-Baptiste Gorin,
Catherine Maurel,
Lucile Drujont,
Sébastien Gouard,
Cédric Louvet,
Michel Chérel,
Alain Faivre-Chauvet,
Alfred Morgenstern,
Frank Bruchertseifer

Published: June 22, 2015
https://doi.org/10.1371/journal.pone.0130249

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Cancer immunotherapy
Is the Subject Area "Cancer immunotherapy" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Radiation therapy
Is the Subject Area "Radiation therapy" applicable to this article?

Thanks for your feedback.